Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

New China Life Insurance - A (601336.SS)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Rmb)	Price Target (Rmb)	Rating
2021-08-20	40.38	49.60	Neutral
2021-11-16	38.66	40.70	Neutral
2022-03-30	34.93	36.70	Neutral
2022-08-16	27.67	30.00	Neutral
2023-02-03	30.45	43.90	Buy
2023-04-28	38.85	46.30	Buy
2023-08-16	42.79	49.60	Buy
2023-11-07	32.84	44.70	Buy
2024-03-29	29.82	43.50	Buy
2024-10-31	48.01	57.10	Buy

Disclosures

Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS Securities Hong Kong Limited is a market maker in the Hong Kong-listed securities of this company.
Market capitalisation is calculated by multiplying the current share price by the sum of A and H shares.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.